サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1520495

心血管デバイス市場レポート：デバイスタイプ、用途、エンドユーザー、地域別、2024年～2032年

Cardiovascular Devices Market Report by Device Type, Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, and Others), End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
心血管デバイス市場レポート：デバイスタイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心血管デバイスの市場規模は2023年に589億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに986億米ドルに達し、2024年から2032年の間に5.8%の成長率（CAGR）を示すと予測しています。良好な償還政策と相まって、インターベンショナル・カーディオロジー手技のイントロダクションが市場成長を刺激しています。

心血管デバイス市場分析：

主な市場促進要因：心不全、冠動脈疾患、不整脈などの心血管疾患の増加が市場を促進しています。さらに、より早い回復、入院期間の短縮、患者の快適性の向上などのために、従来の開心術に代わる低侵襲手術に対する消費者の志向の高まりも、もう1つの重要な成長促進要因として作用しています。

主な市場動向：3Dプリンティングや人工知能（AI）技術の進歩が進み、精度と安全性が強化された先進的な心臓血管機器の発売につながっていることは、市場全体を刺激する新たな動向の1つです。

地理的動向：整備されたヘルスケアインフラが北米市場を強化しています。これとは別に、大手医療機器メーカーの存在と研究開発活動への投資の増加が、この地域の市場にさらにプラスの影響を与えています。

競合情勢：心血管デバイス市場の概要によると、世界市場の著名企業には、Abbott Laboratories、B. Braun Melsungen AG、Biotronik、Boston Scientific Corporation、Canon Medical Systems Corporation、Cardinal Health Inc.、Edwards Lifesciences Corporation、General Electric Company、LivaNova PLC、Medtronic PLC、Siemens Healthineers GmbH（Siemens AG）、Terumo Cardiovascular Systems Corporation（テルモ株式会社）などがあります。

課題と機会：心血管デバイスの発売には、複雑なエンジニアリングと先端材料の統合が必要であり、これが市場成長の妨げとなる可能性があります。しかし、主要企業はこれらの機器、特に埋め込み型機器の長期的な信頼性と安全性を確保しています。このことは、今後数年間も世界市場を拡大し続けると思われます。

心血管デバイス市場動向：

低侵襲手術の需要

従来の開心術から、回復時間の短縮、手術リスクの低減、患者の転帰の改善などを実現する低侵襲手法へと個人の嗜好がシフトしていることが、市場を刺激しています。例えば、2024年4月、ゴールウェイ大学の研究者チームが監修したFAST TRACK CABG調査は、心臓バイパス手術の計画、誘導、実施に対する新しいアプローチを初めて患者を対象に試験しました。この研究では、AIを活用した血流スキャンによる非侵襲的心臓CTが実現可能で安全であることが実証されました。このほか、ロボット工学やリアルタイム画像技術の普及により、大きな切開を必要とせずに弁やステントなどの正確な設置が容易になり、心血管デバイス市場の収益も上昇しています。例えば、2024年2月、フィリップスはFiber Optic RealShape（FORS）技術を搭載したLumiGuideを発表し、放射線を使用しない低侵襲手術を実現しました。これとは別に、低侵襲手術は、特殊な心血管系器具と高度な画像技術を用いて小切開で行われ、これにより標的を絞った精密な治療が可能になります。一般的な例としては、経カテーテル僧帽弁形成術（TMVR）、経カテーテル大動脈弁置換術（TAVR）、内視鏡的静脈採取術などがあります。その結果、これらは世界中で人気を集めています。例えば、2022年12月、世界有数のヘルスケア企業であるアボット社は、手術リスクが高いか極めて高い重症の大動脈弁狭窄症のインド人患者を対象に、新規の経カテーテル大動脈弁移植（TAVI）システム、ナビトールの発売を発表しました。技術の進歩に伴い、これらの手技はより効果的かつ安全になってきており、その結果、多くの心血管系疾患の治療に採用されるようになってきています。例えば、2024年5月、心血管造影・インターベンション学会（SCAI）の年次総会で発表された新しい1年間のデータによると、Anteris Technologies社が開発した新しい生体模倣型経カテーテル大動脈弁置換術（TAVR）システムは、重度の大動脈弁狭窄症（AS）を治療する新しい方法を心臓専門医に提供することができます。

改良型イントロダクション

心血管機器は、慢性心疾患や脳卒中の治療、診断、管理において重要な役割を果たしています。その結果、主要企業は、医療専門家が心血管疾患の重症度を正確に評価し、患者の心臓の健康をモニターし、効果的な治療法を改善することなどを可能にする新しい機器を発売しています。さらに、心血管疾患に対処するために介入を必要とする患者の増加により、スマートステント、植え込み型ペースメーカー、除細動器などの人気が高まっています。これは、心血管デバイス市場の見通しにプラスの影響を与えています。例えば、2023年12月、テルモ・インドは冠動脈疾患の治療を目的とした薬剤溶出ステント「Ultimaster Nagomi」の発売を発表しました。このほか、ペースメーカーを含む改良型心臓血管機器の導入に向けた研究開発活動への投資が拡大していることも、大きな成長促進要因として作用しています。例えば、2023年5月、心臓リズム管理分野の世界の開発企業の1つであるMicroPort社は、幅広い植込み型ペースメーカーであるAlizeaとCeleaのFDA承認を取得しました。また、マイクロポート社が発明したアルゴリズムであるAutoMRIモードを搭載し、MRI検査を受ける患者の安全性を高めています。同様に、2023年7月、アボット社はリードレスペースメーカーシステム、アベイルDRのFDA承認を発表しました。さらに、機械学習とAIは、治療計画の個別化、患者の転帰の予測、診断精度の向上などを目的として、膨大な心血管データの分析に採用されています。例えば、2024年1月、米国メイヨークリニックの循環器専門医の一人であるDemilade Adedinsewo博士が率いる調査は、AI対応のデジタル聴診器が、妊娠中の女性の心筋を弱らせる、生命を脅かす可能性のある疾患である周産期心筋症の診断を改善する可能性を示唆しました。

戦略的パートナーシップ

著名な企業、医療機器メーカー、研究機関、ヘルスケア機関は、精密な画像診断ツールを含む心血管機器を導入するために、共同研究やM&A活動を行っています。これは、心血管デバイス市場の最近のビジネスチャンスの一つです。例えば、2023年9月、主要な心臓データ管理プラットフォームの1つであるPaceMateは、単一のクラウドネイティブ環境で心臓データとEHRデータのワークフローソリューションを構築するため、MedAxiomとの提携を発表しました。これに伴い、2023年10月、GEヘルスケアはボストン・サイエンティフィックと協業し、強化された心臓画像システムを開発しました。さらに、このような提携は、複雑な規制状況を乗り切ったり、国際市場への参入を図ったりする際に、提携先の現地専門知識や確立された販売網を活用することで、企業を支援します。例えば、2023年6月、フィリップスはバイオトロニックとパートナーシップを締結し、フィリップスのシンフォニースイート顧客向けに利用可能な心血管機器の範囲を拡大しました。これ以外にも、2023年5月にペースメイトは、FDA認可の個人用心電図技術と遠隔患者管理ソリューションの世界的リーダーの1つであるAliveCorと提携し、植え込み型心臓機器を包含するようになった。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の心血管デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：デバイスタイプ別

  • 診断および監視デバイス
    • 市場動向
    • 主要セグメント
      • 心電図（ECG）
      • 遠隔心臓モニタリング
      • その他
    • 市場予測
  • 治療および外科用機器
    • 市場動向
    • 主要セグメント
      • 心拍リズム管理（CRM）デバイス
      • カテーテル
      • ステント
      • 心臓弁
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 冠動脈疾患（CAD）
    • 市場動向
    • 市場予測
  • 心不整脈
    • 市場動向
    • 市場予測
  • 心不全
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 専門クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik
    • Boston Scientific Corporation
    • Canon Medical Systems Corporation
    • Cardinal Health Inc.
    • Edwards Lifesciences Corporation
    • General Electric Company
    • LivaNova PLC
    • Medtronic PLC
    • Siemens Healthineers GmbH（Siemens AG）
    • Terumo Cardiovascular Systems Corporation（Terumo Corporation）
図表

List of Figures

  • Figure 1: Global: Cardiovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiovascular Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cardiovascular Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cardiovascular Devices Market: Breakup by Device Type (in %), 2023
  • Figure 5: Global: Cardiovascular Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Cardiovascular Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Cardiovascular Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cardiovascular Devices (Heart Failure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cardiovascular Devices (Heart Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cardiovascular Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cardiovascular Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cardiovascular Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cardiovascular Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cardiovascular Devices (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cardiovascular Devices (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cardiovascular Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cardiovascular Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Cardiovascular Devices Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Cardiovascular Devices Industry: SWOT Analysis
  • Figure 76: Global: Cardiovascular Devices Industry: Value Chain Analysis
  • Figure 77: Global: Cardiovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiovascular Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cardiovascular Devices Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 3: Global: Cardiovascular Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Cardiovascular Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Cardiovascular Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cardiovascular Devices Market: Competitive Structure
  • Table 7: Global: Cardiovascular Devices Market: Key Players
目次
Product Code: SR112024A5240

The global cardiovascular devices market size reached US$ 58.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 98.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth.

Cardiovascular Devices Market Analysis:

Major Market Drivers: The increasing number of cardiovascular conditions, such as heart failure, coronary artery disease, arrhythmias, etc., is propelling the market. Moreover, the rising consumer inclination towards minimally invasive alternatives to traditional open-heart surgeries for faster recovery, reduced hospital stays, improved patient comfort, etc., is also acting as another significant growth-inducing factor.

Key Market Trends: The growing advancements in 3D printing and artificial intelligence (AI) technologies that are leading to the launch of advanced cardiovascular devices to offer enhanced precision and safety are among the emerging trends stimulating the overall market.

Geographical Trends: The well-developed healthcare infrastructures are bolstering the market in North America. Apart from this, the presence of major medical device manufacturers and the elevating investments in R&D activities are further positively influencing the regional market.

Competitive Landscape: According to the cardiovascular devices market overview, some of the prominent companies across the global market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG), and Terumo Cardiovascular Systems Corporation (Terumo Corporation), among many others.

Challenges and Opportunities: The launch of cardiovascular devices involves complex engineering and integration of advanced materials, which can hamper the market growth. However, key players are ensuring the long-term reliability and safety of these devices, particularly those that are implantable. This, in turn, will continue to augment the global market in the coming years.

Cardiovascular Devices Market Trends:

Demand for Minimally Invasive Procedures

The shifting preferences of individuals from traditional open-heart surgeries toward less invasive methodologies that minimize recovery times, reduce surgical risks, improve patient outcomes, etc., are stimulating the market. For example, in April 2024, the FAST TRACK CABG study, overseen by a team of researchers at the University of Galway, tested a new approach to the planning, guidance, and conducting of heart bypass surgery on patients for the first time. It demonstrated that non-invasive cardiac CT with AI-powered blood flow scanning is feasible and safe. Besides this, the widespread adoption of robotics and real-time imaging techniques facilitates the accurate placement of valves, stents, and other devices without the need for large incisions, which is also elevating the cardiovascular devices market revenue. For instance, in February 2024, Philips introduced LumiGuide, which is powered by Fiber Optic RealShape (FORS) technology, for radiation-free, minimally invasive surgeries. Apart from this, minimally invasive procedures are performed via small incisions using specialized cardiovascular instruments and advanced imaging techniques, which allow for targeted and precise treatments. Some of the common examples include transcatheter mitral valve repair (TMVR), transcatheter aortic valve replacement (TAVR), endoscopic vein harvesting, etc. Consequently, they are gaining traction across the globe. For example, in December 2022, Abbott, one of the leading global healthcare companies, announced the launch of its novel transcatheter aortic valve implantation (TAVI) system, Navitor, for individuals in India with severe aortic stenosis who are at high or extreme surgical risk. As technology advances, these procedures are becoming more effective and safer, thereby leading to their increasing adoption in treating numerous cardiovascular conditions. For instance, in May 2024, according to new one-year data presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI), a new biomimetic transcatheter aortic valve replacement (TAVR) system developed by Anteris Technologies can offer cardiologists with a new way to treat severe aortic stenosis (AS).

Introduction of Enhanced Variants

Cardiovascular devices play a crucial role in the treatment, diagnosis, and management of chronic heart conditions and stroke. Consequently, key players are launching novel devices that enable healthcare professionals to accurately assess the severity of cardiovascular diseases, monitor the heart health of patients, improve effective therapies, etc. Moreover, the increasing number of patients requiring intervention to address their cardiovascular conditions is escalating the popularity of smart stents, implantable pacemakers, defibrillators, etc. This, in turn, is positively influencing the cardiovascular devices market outlook. For example, in December 2023, Terumo India announced the launch of Ultimaster Nagomi, a drug-eluting stent intended for use in the treatment of coronary artery disease. Besides this, the growing investments in R&D activities to introduce improved cardiovascular devices, including pacemakers, are acting as significant growth-inducing factors. For instance, in May 2023, MicroPort, one of the global developers in the field of cardiac rhythm management, received FDA approval for its wide range of implantable pacemakers, Alizea and Celea. Additionally, they feature AutoMRI mode, an algorithm invented by MicroPort, that increases the safety of patients who are undergoing an MRI examination. Similarly, in July 2023, Abbott announced the FDA approval of its leadless pacemaker system, Aveir DR. Furthermore, machine learning and AI are employed for analyzing vast amounts of cardiovascular data to personalize treatment plans, predict patient outcomes, improve diagnostic accuracies, etc. For example, in January 2024, research led by Dr. Demilade Adedinsewo, one of the cardiologists at the Mayo Clinic in the U.S., suggested that the AI-enabled digital stethoscope could improve the diagnosis of peripartum cardiomyopathy, a potentially life-threatening condition that weakens the heart muscle of women during pregnancy.

Strategic Partnerships

Prominent companies, medical device manufacturers, research institutions, and healthcare organizations are collaborating and entering into mergers and acquisitions activities to introduce cardiovascular devices, including precise imaging tools. This represents one of the cardiovascular devices market recent opportunities. For instance, in September 2023, PaceMate, one of the leading cardiac data management platforms, announced the partnership with MedAxiom to create workflow solutions for cardiac and EHR data in a single, cloud-native environment. In line with this, in October 2023, GE HealthCare collaborated with Boston Scientific to develop enhanced cardiac imaging systems. Additionally, these partnerships aid companies in navigating complex regulatory landscapes and gaining access to international markets by leveraging the local expertise and established distribution networks of their partners. For example, in June 2023, Philips entered into a partnership with Biotronik to expand the range of cardiovascular devices available for Philips SymphonySuite customers. Besides this, in May 2023, PaceMate collaborated with AliveCor, one of the global leaders in FDA-cleared personal electrocardiogram technology and remote patient management solutions, to encompass implantable cardiac devices.

Cardiovascular Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the cardiovascular devices market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the device type, application, and end user.

Breakup by Device Type:

Diagnostic and Monitoring Devices

Electrocardiogram (ECG)

Remote Cardiac Monitoring

Others

Therapeutic and Surgical Devices

Cardiac Rhythm Management (CRM) Devices

Catheter

Stents

Heart Valves

Others

Therapeutic and surgical devices is the most popular device type

The report has provided a detailed breakup and analysis of the market based on the device type. This includes diagnostic and monitoring devices (electrocardiogram (ECG) remote cardiac monitoring, and others) and therapeutic and surgical devices (cardiac rhythm management (CRM) devices, catheter, stents, heart valves, and others). According to the report, therapeutic and surgical devices represent the largest segment.

The increasing number of surgical procedures and therapeutic interventions aimed at treating cardiovascular diseases is propelling the segment's growth. Moreover, therapeutic and surgical devices include implantable cardioverter defibrillators (ICDs), stents, pacemakers, catheters, heart valves, ventricular assist devices (VADs), etc. They aid in regulating heart rhythm, restoring blood flow, providing mechanical circulatory support, etc. Consequently, they are gaining extensive traction as less invasive alternatives to traditional open-heart surgeries, which is elevating the cardiovascular devices market demand. For example, in December 2023, Medtronic plc, one of the global leaders in healthcare technologies, announced the FDA approval of the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). In line with this, in June 2023, Magenta Medical launched a feasibility study for the world's smallest heart pump that reduces vascular access complications during heart surgery.

Breakup by Application:

Coronary Artery Disease (CAD)

Cardiac Arrhythmia

Heart Failure

Others

Coronary artery disease (CAD) dominates the cardiovascular devices market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes coronary artery disease (CAD), cardiac arrhythmia, heart failure, and others. According to the report, coronary artery disease (CAD) represented the largest market segmentation.

CAD devices used for treatment, diagnosis, and management of coronary artery disease condition are gaining traction across countries. Moreover, the widespread adoption of diagnostic devices, such as intravascular ultrasound (IVUS) devices, angiography systems, and computed tomography angiography (CTA) machines, as they help in assessing the severity of coronary artery blockages, is propelling the market. For example, in August 2022, Medtronic announced the launch of its novel drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES), following CE Mark approval. Besides this, in January 2024, Cleerly, one of the companies working to create a new standard of care for the diagnosis of heart disease, introduced Cleerly ISCHEMIA, which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance. Cleerly ISCHEMIA analysis software is an automated machine learning-based decision support tool specifically designed for patients undergoing coronary computed tomography angiography (CCTA).

Breakup by End User:

Hospitals

Specialty Clinics

Others

Hospitals account for the majority of the overall market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, specialty clinics, and others. According to the report, hospitals represented the largest segment.

Hospitals are the primary end users of cardiovascular devices. They provide a wide range of cardiac services, such as treatment, diagnosis, and surgical procedures for cardiovascular diseases. Hospitals have cardiac catheterization labs and specialized cardiology departments equipped with advanced imaging systems and surgical suites, which is increasing the cardiovascular devices market's recent price. For instance, in January 2024, Sylvia Jones, the health minister of Ontario, announced the development of a new cardiac lab at St. Mary's General Hospital in Kitchener, Canada, to help cardiac patients. They require a comprehensive range of devices, such as implantable devices, diagnostic equipment, surgical instruments, monitoring systems, etc., which is driving the growth in this segmentation.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest market for cardiovascular devices.

The increasing prevalence of cardiovascular conditions, including stroke and peripheral artery disease, is propelling the regional market. For instance, as per the report published by the Heart and Stroke Foundation of Canada in February 2022, there were 750,000 patients diagnosed with heart failure. Moreover, favorable reimbursement policies and fast regulatory approvals are acting as significant growth-inducing factors. For example, in September 2023, CorVista Health announced the FDA approval of its non-invasive medical device system that is used for detecting the presence of cardiac disease. In line with this, in January 2024, Occlutech, a Swedish medical device company focused on structural heart disease, received the U.S. FDA approval for its ASD Occluder for the treatment of atrial septal defects (ASDs). Apart from this, as per the cardiovascular devices market statistics, the introduction of wireless ECG has allowed for real-time patient monitoring and diagnosis. This, in turn, will continue to stimulate the regional market in the coming years. For example, in February 2021, VivaLNK developed a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).

Competitive Landscape:

The key players are investing significantly in R&D to develop innovative cardiovascular devices. They focus on improving device performance, durability, and patient outcomes. R&D efforts aim to introduce advanced technologies, such as minimally invasive procedures, remote monitoring systems, and personalized medicine approaches. Additionally, cardiovascular devices market companies are continuously launching new cardiovascular devices to expand their product portfolios. These launches often involve next-generation devices with improved features and enhanced capabilities. They are prioritizing addressing unmet clinical needs, such as novel therapies for specific cardiovascular conditions or devices that offer improved precision and ease of use. Besides this, collaborations and partnerships between key players, healthcare providers, and research institutions are common in the cardiovascular devices market. These collaborations foster innovation, facilitate knowledge exchange, and leverage collective expertise and resources to develop and commercialize new technologies and solutions.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

B. Braun Melsungen AG

Biotronik

Boston Scientific Corporation

Canon Medical Systems Corporation

Cardinal Health Inc.

Edwards Lifesciences Corporation

General Electric Company

LivaNova Plc

Medtronic Plc

Siemens Healthineers GmbH (Siemens AG)

Terumo Cardiovascular Systems Corporation (Terumo Corporation)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Cardiovascular Devices Market Recent Developments:

May 2024: According to new one-year data presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI), a new biomimetic transcatheter aortic valve replacement (TAVR) system developed by Anteris Technologies can offer cardiologists with a new way to treat severe aortic stenosis (AS).

May 2024: According to the article published in the journal npj Fexible Electronics, a team of researchers from China presented a novel approach to use wearable sensors for assessing vascular age and cardiovascular diseases.

April 2024: The FAST TRACK CABG study, overseen by a team of researchers at the University of Galway, tested a new approach to the planning, guidance, and conducting of heart bypass surgery on patients for the first time.

January 2024: India Medtronic Private Limited announced a strategic collaboration with Cardiac Design Labs (CDL) to scale up, launch, and expand access to CDL's novel diagnostic technology, Padma Rhythms, an external loop recorder (ELR) patch designed for long-term and comprehensive heart monitoring and diagnosis.

Key Questions Answered in This Report

  • 1. What was the size of the global cardiovascular devices market in 2023?
  • 2. What is the expected growth rate of the global cardiovascular devices market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global cardiovascular devices market?
  • 4. What are the key factors driving the global cardiovascular devices market?
  • 5. What is the breakup of the global cardiovascular devices market based on the device type?
  • 6. What is the breakup of the global cardiovascular devices market based on the application?
  • 7. What is the breakup of the global cardiovascular devices market based on the end user?
  • 8. What are the key regions in the global cardiovascular devices market?
  • 9. Who are the key players/companies in the global cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Electrocardiogram (ECG)
      • 6.1.2.2 Remote Cardiac Monitoring
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.2.2 Catheter
      • 6.2.2.3 Stents
      • 6.2.2.4 Heart Valves
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Heart Failure
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Biotronik
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Canon Medical Systems Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Cardinal Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Edwards Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 General Electric Company
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 LivaNova PLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Medtronic PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Siemens Healthineers GmbH (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Terumo Cardiovascular Systems Corporation (Terumo Corporation)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio